Clinical Trial

Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
MicroPort Orthopedics (MPO) is conducting this PMCF study to evaluate the safety and efficacy of its THA and resurfacing components marketed in the EU. These types of studies are required by regulatory authorities for all THA and resurfacing devices that do not have medium to long-term clinical evidence available at the time of gaining approval to market in the EU. This study has been designed in accordance with MEDDEV 2.12/2 rev 2.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2014-11-05; most recent amendment 2023-06-06.
Status change: Enrolling by Invitation → Active, Not Recruiting 2022-04-13
Status change: Recruiting → Enrolling by Invitation 2015-10-16
Status change: Not Yet Recruiting → Recruiting 2015-01-06
Trial Details
NCT Number NCT02285842
Lead Sponsor MicroPort Orthopedics Inc.
Conditions Joint Disease
Enrollment 143 participants
Start Date 2014-12
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2023-06-07